SUDARSHAN PHARMA IND LTD (SUDARSHAN) financials

SUDARSHAN PHARMA IND LTD (SUDARSHAN) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Incorporated in 2008, Sudarshan Pharma Industries Ltd manufactures API and Pharmaceutical Items. It also trades in Chemicals and Solvents[1]

Market Cap: ₹882Cr.
Current Price: ₹34.7
Stock P/E: 36.3
ROE: 14.6%
ROCE: 14.3%
Book Value: ₹6.35
Dividend Yield: 0.00%
52W High / Low: ₹42.8/18.5

In Jun 2026, SUDARSHAN PHARMA IND LTD (SUDARSHAN) reported sales ₹165.66 Cr and net profit ₹6.04 Cr.

Annual TTM: sales ₹691 Cr, net profit ₹24 Cr.

Shareholding: Promoters 57.81% (Sep 2026), FIIs 21.94% (Sep 2026), Government 0.05% (Sep 2026), Public 20.19% (Sep 2026), No. of Shareholders 1,250% (Sep 2026).

SUDARSHAN quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	123.62	115.58	161.57	142.31	167.01	158.37	199.81	165.66
Expenses	111.21	107.61	146.36	132.03	157.40	147.60	181.51	149.39
Operating Profit	12.41	7.97	15.21	10.28	9.61	10.77	18.30	16.27
OPM %	10.04%	6.90%	9.41%	7.22%	5.75%	6.80%	9.16%	9.82%
Other Income	-0.58	0.57	-0.74	1.41	2.09	1.69	3.21	1.35
Interest	3.96	4.05	4.44	5.71	6.07	6.24	7.27	8.19
Depreciation	0.65	0.66	0.76	0.79	0.81	0.81	1.00	1.29
Profit before tax	7.22	3.83	9.27	5.19	4.82	5.41	13.24	8.14
Tax %	25.07%	28.20%	24.27%	28.13%	8.92%	20.52%	27.87%	25.80%
Net Profit	5.42	2.76	7.03	3.73	4.40	4.31	9.54	6.04
EPS in Rs	0.23	0.11	0.29	0.15	0.18	0.18	0.40	0.24
Raw PDF	—	—	—	—	—	—	—	—

SUDARSHAN profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	148	193	357	461	466	502	668	691
Expenses	143	186	346	446	443	465	619	636
Operating Profit	5	7	11	15	23	38	49	55
OPM %	3.2%	3.8%	3.1%	3.2%	4.9%	7%	7%	8%
Other Income	0	0	0	1	3	0	8	8
Interest	3	3	3	5	9	16	25	28
Depreciation	0	1	1	1	1	3	3	4
Profit before tax	2	4	7	10	15	19	29	32
Tax %	26%	25%	26%	26%	25%	25%	23%	—
Net Profit	1	3	5	7	11	14	22	24
EPS in Rs	0.09	0.19	0.36	0.29	0.47	0.58	0.91	1.00
Dividend Payout %	0%	0%	0%	10%	0%	0%	0%	—

SUDARSHAN balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	10	10	10	10	24	24	24	24
Reserves	9	10	13	20	77	88	107	129
Borrowings	14	21	30	31	34	107	177	282
Other Liabilities	17	18	47	77	97	66	96	159
Total Liabilities	50	58	99	138	232	285	403	594
Fixed Assets	2	6	6	6	20	21	42	94
CWIP	2	0	0	1	0	2	23	3
Investments	0	0	0	0	12	17	5	8
Other Assets	47	53	93	130	200	245	334	489
Total Assets	50	58	99	138	232	285	403	594

SUDARSHAN cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	-1	1	3	-4	-29	10	-33	-3
Cash from Investing Activity	-4	-3	-1	-2	-26	-9	-20	-80
Cash from Financing Activity	8	-0	-2	4	66	-12	54	82
Net Cash Flow	3	-2	-0	-1	11	-12	0	-0
Free Cash Flow	-5	-4	2	-5	-43	8	-54	-52
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	-2%	20%	51%	-18%	-179%	52%	-81%	6%

SUDARSHAN shareholding pattern (%)
Category	Sep 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	57.39%	57.39%	57.39%	57.39%	57.39%	57.39%	58.93%	57.81%
FIIs	13.07%	18.45%	19.49%	20.79%	19.78%	19.95%	19.38%	21.94%
Government	0.00%	0.00%	0.05%	0.05%	0.05%	0.05%	0.05%	0.05%
Public	29.54%	24.16%	23.07%	21.76%	22.79%	22.61%	21.65%	20.19%
No. of Shareholders	787	1,212	1,327	1,383	1,407	1,346	1,231	1,250

SUDARSHAN key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	68	66	114	75	64	96	110	109
Inventory Days	29	46	49	51	63	73	114	128
Days Payable	45	40	90	80	78	52	73	91
Cash Conversion Cycle	52	72	73	46	50	117	151	146
Working Capital Days	27	35	29	27	54	60	48	19
ROCE %	20%	12%	15%	19%	15%	14%	14%	14%

SUDARSHANUpdated 27 Oct 2026, 17:59

Sudarshan Pharma Ind Ltd

SUDARSHANUpdated 27 Oct 2026, 17:59

Market Cap

₹882Cr.

Current Price

₹34.7

High / Low

₹42.8/18.5

Stock P/E

36.3

Book Value₹6.35

Dividend Yield0.00%

ROCE14.3%

ROE14.6%

Face Value₹1.00

About

Incorporated in 2008, Sudarshan Pharma Industries Ltd manufactures API and Pharmaceutical Items. It also trades in Chemicals and Solvents[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2024	101.72	3.77	99.75	0.92	0.64	-1.52	-22.37	-1.18	-0.05
Sep 2024	123.62	3.96	111.21	-0.58	0.65	7.22	25.07	5.42	0.23
Dec 2024	115.58	4.05	107.61	0.57	0.66	3.83	28.2	2.76	0.11
Mar 2025	161.57	4.44	146.36	-0.74	0.76	9.27	24.27	7.03	0.29
Jun 2025	142.31	5.71	132.03	1.41	0.79	5.19	28.13	3.73	0.15
Sep 2025	167.01	6.07	157.4	2.09	0.81	4.82	8.92	4.4	0.18
Dec 2025	158.37	6.24	147.6	1.69	0.81	5.41	20.52	4.31	0.18
Mar 2026	199.81	7.27	181.51	3.21	1	13.24	27.87	9.54	0.4
Jun 2026	165.66	8.19	149.39	1.35	1.29	8.14	25.8	6.04	0.24

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2017	55	0	55	0	0	0	40	0	0.03
Mar 2018	88	1	87	2	0	1	24	1	0.06
Mar 2019	139	2	135	1	0	3	28	2	0.16
Mar 2020	148	3	143	0	0	2	26	1	0.09
Mar 2021	193	3	186	0	1	4	25	3	0.19
Mar 2022	357	3	346	0	1	7	26	5	0.36
Mar 2023	461	5	446	1	1	10	26	7	0.29
Mar 2024	466	9	443	3	1	15	25	11	0.47
Mar 2025	502	16	465	0	3	19	25	14	0.58
Mar 2026	668	25	619	8	3	29	23	22	0.91
TTM	691	28	636	8	4	32	—	24	1

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	57.81%
FIIs	21.94%
Government	0.05%
Public	20.19%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	Government	Public
Mar 2023	57.39%	3.58%	0%	39.02%
Sep 2023	57.39%	1.4%	0%	41.2%
Mar 2024	57.39%	1.4%	0%	41.21%
Sep 2024	57.39%	13.07%	0%	29.54%
Mar 2025	57.39%	18.45%	0%	24.16%
Jun 2025	57.39%	19.49%	0.05%	23.07%
Sep 2025	57.39%	20.79%	0.05%	21.76%
Dec 2025	57.39%	19.78%	0.05%	22.79%
Mar 2026	57.39%	19.95%	0.05%	22.61%
Jun 2026	58.93%	19.38%	0.05%	21.65%
Sep 2026	57.81%	21.94%	0.05%	20.19%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2017	2	1	6	11	20	0	0	0	20	20
Mar 2018	5	4	10	12	31	0	0	0	31	31
Mar 2019	10	9	14	17	50	2	2	0	47	50
Mar 2020	10	10	21	18	58	6	0	0	53	58
Mar 2021	10	13	30	47	99	6	0	0	93	99
Mar 2022	10	20	31	77	138	6	1	0	130	138
Mar 2023	24	77	34	97	232	20	0	12	200	232
Mar 2024	24	88	107	66	285	21	2	17	245	285
Mar 2025	24	107	177	96	403	42	23	5	334	403
Mar 2026	24	129	282	159	594	94	3	8	489	594

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2017	-2	0	2	0
Mar 2018	0	0	-1	-1
Mar 2019	-1	-4	8	3
Mar 2020	1	-3	0	-2
Mar 2021	3	-1	-2	0
Mar 2022	-4	-2	4	-1
Mar 2023	-29	-26	66	11
Mar 2024	10	-9	-12	-12
Mar 2025	-33	-20	54	0
Mar 2026	-3	-80	82	0

Key ratios

Historical financial ratios

Category	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	92	71	68	66	114	75	64	96	110	109
Inventory Days	23	28	29	46	49	51	63	73	114	128
Days Payable	75	49	45	40	90	80	78	52	73	91
Cash Conversion Cycle	40	51	52	72	73	46	50	117	151	146
Working Capital Days	42	52	27	35	29	27	54	60	48	19
ROCE %	—	16%	20%	12%	15%	19%	15%	14%	14%	14%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of SUDARSHAN PHARMA IND LTD (SUDARSHAN)?

The reported market capitalisation for SUDARSHAN PHARMA IND LTD (SUDARSHAN) is ₹882Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of SUDARSHAN?

The current price shown for SUDARSHAN PHARMA IND LTD (SUDARSHAN) on Fincrux is ₹34.7 with a 52-week high/low of ₹42.8/18.5.

What is the P/E ratio of SUDARSHAN PHARMA IND LTD (SUDARSHAN)?

The stock P/E for SUDARSHAN PHARMA IND LTD (SUDARSHAN) is 36.3 on Fincrux, with ROE at 14.6% and ROCE at 14.3%.

What were SUDARSHAN latest quarterly results?

For Jun 2026, SUDARSHAN PHARMA IND LTD (SUDARSHAN) reported sales ₹165.66 Cr and net profit ₹6.04 Cr (figures in ₹ crore unless noted).

What are SUDARSHAN annual sales and net profit?

For TTM, SUDARSHAN PHARMA IND LTD (SUDARSHAN) shows sales of ₹691 Cr and net profit of ₹24 Cr on the Fincrux profit & loss statement.

Who owns SUDARSHAN PHARMA IND LTD (SUDARSHAN)?

Latest shareholding for SUDARSHAN PHARMA IND LTD (SUDARSHAN) on Fincrux: Promoters 57.81% (Sep 2026), FIIs 21.94% (Sep 2026), Government 0.05% (Sep 2026), Public 20.19% (Sep 2026), No. of Shareholders 1,250% (Sep 2026).

Where can I find SUDARSHAN PHARMA IND LTD (SUDARSHAN) financials?

SUDARSHAN PHARMA IND LTD (SUDARSHAN) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show SUDARSHAN balance sheet and cash flow?

Yes. The SUDARSHAN PHARMA IND LTD (SUDARSHAN) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 27 October 2026 at 17:59